If the cancer is diagnosed early the death rate is very low because there are successful methods of treatment, but due to the lack of symptoms early on thousands of people die each year of it.
COCONUT OIL DESTROYS 93% OF COLON CANCER CELLS IN 2 DAYS?
Coconut oil has been used for centuries by cultures around the world and lately it has started to get the attention it deserves in modern society as well. It’s beneficial in the treatment against a number of diseases making it one of the healthiest natural ingredients in the world.
Coconut oil is rich in healthy saturated fats, making it an excellent source of fatty acids, commonly found in fish and seeds. Almost 90% of the fatty acids in coconut oil are saturated which makes it one of the best sources of saturated fats found in nature.
Recent research have shown that coconut can help relieve the harmful side effects of chemotherapy, and improve the quality of life for cancer patients, which is why many recommend it as an additional treatment to chemo.
“According to a study published in the journal Cancer Research, the lauric acid in coconut oil has anti-cancer properties. Lauric acid constitutes about 50% of coconut oil, and researchers at the University of Adelaide discovered that it completely exterminated more than 90% of colon cancer cells after just two days of treatment in a colon cancer cell line in vitro. Researchers also cited other studies that support their findings.”
Lauric acid, which is also found in mother’s milk, is a fatty acid that strengthens the immune system and has strong anti-bacterial properties.
The study involved in vitro experiments in petri dishes, as well as in vivo in rats. Both experiments gave the same results. It found that lauric acid destroys cancer cells while causing oxidative stress. This significantly reduces the level of glutathione, which cancer cells depend on.
The real problem is that research of this kind is enormously expensive and unappealing to sponsors because natural cures can’t be patented. This simply holds no interest to pharmaceuticals companies to finance such trials, despite the fact that they target the wellbeing of the entire population.